MAPLE GROVE, Minn., Jan. 28, 2019 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a US-based pharmaceutical company that has successfully delivered medications to the people who need them for 100 years, proudly kicked off its centennial anniversary this month at its headquarters in Maple Grove, MN. Employees came together on January 10, 2019 to mark 100 years of Upsher-Smith's heritage of formulating and manufacturing quality generics that has led to improving the lives of hundreds of thousands of patients.
In 1919, a young English-born pharmacist, Fredrick Alfred Upsher Smith, created Upsher-Smith, a company where he envisioned honesty and ethics as its driving force along with a constant focus on the welfare of patients and customers. With these guiding principles, Upsher-Smith quickly developed a reputation for excellence by perfecting the refinement of digitalis from the foxglove plant and producing it in a standardized potency with consistency in dosage from one batch to the next, an advancement never before achieved in the 134 years since the drug's discovery.
"As we reflect on the people, products and innovation that drove a period of rapid growth for Upsher-Smith over the last century, we are reminded that our steadfast commitment to improving the health and lives of patients through high-quality products and sustainable growth will drive us into our second century," said Rusty Field, President and CEO of Upsher-Smith.
Upsher-Smith will begin the new century with its most aggressive new product growth plan in its history. The company plans to diversify and expand its portfolio of products while forging new partnerships that drive future innovation and growth.
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. Since 1919, it has brought generics and brands to a wide array of customers backed by an attentive level of service, strong industry relationships, and dedication to uninterrupted supply.
As Upsher-Smith celebrates its 100-year anniversary, the company enters a new ambitious era that has been accelerated by its 2017 acquisition by Sawai Pharmaceutical Co., Ltd. Upsher-Smith and Sawai plan to leverage each other for growth worldwide and embark on an exciting new chapter as they seek to deliver the best value for their stakeholders, and most importantly, do more good for the patients they serve. For more information, visit www.upsher-smith.com.
SOURCE Upsher-Smith Laboratories, LLC